(Q37285966)

19 August 2017

1 reference

title

Chemotherapy for glioblastoma: is costly better? (English)

1 reference

19 August 2017

1 reference

1 reference

Ute Linz

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

113

1 reference

19 August 2017

issue

10

1 reference

19 August 2017

page(s)

2617-2622

1 reference

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Factors influencing survival in high-grade gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Cell specific differences in O6-methylguanine-DNA methyltransferase activity and removal of O6-methylguanine in rat pulmonary cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Protective effect of O6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase π in glioblastoma and the survival of the patients treated with nimustine hydrochloride: An immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23884

7 January 2021

Identifiers

DOI

10.1002/CNCR.23884

1 reference

19 August 2017

1 reference